Pharmaceuticals China

China PCOS Treatment Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

China PCOS Treatment Market Industry Trends and Forecast to 2034: Segmented by (Treatment, Symptom, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

China · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $491.3 Mn Placeholder estimate
Estimate 2025 $527.2 Mn 8% of the global market
Projected 2034 $994.0 Mn 88.5% Adds $466.8 Mn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 21% of 180 Pharmaceuticals markets here
Key players 5
  • China is 8.03% of the global market.
  • In APAC, the largest is China (this report) at $527.2 Mn.
  • Fastest growing: India at 8.2% a year.
  • China ranks 1st of 10 by size in APAC.

Market size projection

China

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$466.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
PCOS Treatment Market market size by year, China
YearMarket sizeChange that yearSince 2025
2024 (estimate) $491.3 Mn — —
2025 (base) $527.2 Mn +$35.9 Mn —
2026 (forecast) $565.7 Mn +$38.5 Mn +7.3%
2027 (forecast) $607.0 Mn +$41.3 Mn +15.1%
2028 (forecast) $651.3 Mn +$44.3 Mn +23.5%
2029 (forecast) $698.8 Mn +$47.5 Mn +32.6%
2030 (forecast) $749.8 Mn +$51.0 Mn +42.2%
2031 (forecast) $804.6 Mn +$54.7 Mn +52.6%
2032 (forecast) $863.3 Mn +$58.7 Mn +63.8%
2033 (forecast) $926.3 Mn +$63.0 Mn +75.7%
2034 (forecast) $994.0 Mn +$67.6 Mn +88.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $6.57 Bn
  2. North America $3.11 Bn
  3. US $2.89 Bn
  4. APAC $1.44 Bn
  5. Europe $1.06 Bn
  6. China (this report) $527.2 Mn
  7. Canada $463.2 Mn
  8. Japan $392.2 Mn
  9. Latin America $269.6 Mn
  10. Germany $249.4 Mn
  11. Middle East $246.1 Mn
  12. France $195.9 Mn
  13. Brazil $191.2 Mn
  14. Italy $155.8 Mn
  15. UK $151.7 Mn
  16. Ecuador $138.7 Mn
  17. India $133.7 Mn
  18. Spain $112.5 Mn
  19. Mexico $103.2 Mn
  20. Saudi Arabia $99.3 Mn
  21. Africa $87.0 Mn
  22. New Zealand $74.3 Mn
  23. Russia $69.2 Mn
  24. Australia $68.7 Mn
  25. South Africa $46.3 Mn
  26. UAE $29.4 Mn
  27. Egypt $21.4 Mn
  28. Philippines $16.2 Mn
  29. Malaysia $12.1 Mn
  30. Hong Kong $11.3 Mn
  31. Thailand $8.8 Mn
  32. Singapore $7.7 Mn
  33. Kenya $4.9 Mn

Report snapshot

China PCOS Treatment Market Analysis at a glance
Market size, 2025$527.2 Mn placeholder estimate
Forecast, 2034$994.0 Mn placeholder estimate
Growth (CAGR), 2025–20347.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
Also calledPolycystic Ovarian Syndrome Treatment
SegmentsTreatment, symptom and end user (see all)
Key playersBayer AG, Merck & Co., Inc., Ferring Pharmaceuticals, Novo Nordisk A/S, Organon (see all)
Regulator in ChinaNMPASource: National Medical Products Administration. Checked 14 Nov 2026.
Active clinical trials23 in ChinaSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The China PCOS Treatment Market Analysis Executive Summary

PCOS treatment manages polycystic ovary syndrome, a hormone condition that can cause irregular periods, weight gain, acne and infertility.

Key segments of the PCOS Treatment market include treatment (Oral Contraceptives, Insulin Sensitizers and Anti-Androgens) and symptom (Menstrual Irregularity, Infertility and Metabolic Symptoms).

Bar chart: China PCOS Treatment market size, 2024–2034, placeholder estimates. $491.3 Mn in 2024, $527.2 Mn in 2025 and $994.0 Mn in 2034, 7.3% CAGR.
China PCOS Treatment market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

China PCOS Treatment Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the PCOS Treatment market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the PCOS Treatment market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the PCOS Treatment market.

Competitive Landscape for PCOS Treatment Market in China

The PCOS Treatment market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for PCOS Treatment Market in China

PCOS Treatment in China: rules, payment and research

Drugs need approval from the National Medical Products Administration (NMPA) before sale.⁠[1] Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List.⁠[2] ClinicalTrials.gov lists 23 studies on PCOS Treatment that are recruiting, active or about to start in China.⁠[3]

[1] National Medical Products Administration. Checked 14 Nov 2026.

[2] National Healthcare Security Administration. Checked 14 Nov 2026.

[3] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for PCOS Treatment. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in China.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in PCOS Treatment right now, from free public sources.

Latest research 159 papers since 2021 (worldwide)

  1. Roles and Biological Effects of Polysaccharides in Polycystic Ovary Syndrome: A Narrative Review. Reproductive sciences (Thousand Oaks, Calif.), 2026
  2. The Gut-Insulin Axis in Polycystic Ovary Syndrome: A Narrative Review of Gut Dysbiosis, Inflammation, and Emerging Therapeutic Strategies. Reproductive sciences (Thousand Oaks, Calif.), 2026
  3. Neddylation inhibition alleviates polycystic ovary syndrome by regulating granulosa cell function and androgen synthesis. Biology of reproduction, 2026
  4. Identification of CA2 as a potential candidate gene involved in the therapeutic effect of Huatan Huoxue decoction on polycystic ovary syndrome: An integrated study of network pharmacology, Mendelian randomization, and experimental validation. Journal of food and drug analysis, 2026
  5. Elucidating the Molecular Mechanisms of Vitex negundo L. in Polycystic Ovary Syndrome via Metabolomics-Driven Network Pharmacology. Biomedical chromatography : BMC, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

PCOS Treatment in context

China compared

  • Health spending per person: 763 US$ per person (2023). World: 1,317 US$ per person (2023). 5th highest of the 15 countries we cover in APAC.[1]
  • Doctors: 3.11 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 3rd highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.9% of people (2025). World: 10.4% of people (2025). 6th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the PCOS Treatment market in China?
Placeholder estimate: about $527.2 Mn in 2025, rising to about $994.0 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the PCOS Treatment market in China growing?
Placeholder estimate: about 7.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the PCOS Treatment market report cover?
The report splits the market by treatment (Oral Contraceptives, Insulin Sensitizers, Anti-Androgens, Fertility Drugs and more), symptom (Menstrual Irregularity, Infertility, Metabolic Symptoms, Hirsutism) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the PCOS Treatment market?
Key players include Bayer AG, Merck & Co., Inc., Ferring Pharmaceuticals, Novo Nordisk A/S and Organon.
What is driving the PCOS Treatment market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the PCOS Treatment market. New products designed around women's biology and digital care are improving access.
Who regulates PCOS Treatment in China?
Drugs need approval from the National Medical Products Administration (NMPA) before sale. Source: National Medical Products Administration. Checked 14 Nov 2026.
How is healthcare paid for in China?
Basic medical insurance covers most people; the National Healthcare Security Administration (NHSA) runs it and sets the National Reimbursement Drug List. Source: National Healthcare Security Administration. Checked 14 Nov 2026.
How many clinical trials on PCOS Treatment are running in China?
23 studies are recruiting, active or about to start in China, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in China. Retrieved 12 Nov 2026.
How much research is published on PCOS Treatment?
PubMed lists 159 papers on PCOS Treatment added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about PCOS Treatment in China? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Breast Cancer Screening and Diagnosis: Closing the GapBreast cancer is the most common cancer in women worldwide. Finding it early saves lives, but access to… Fertility Services: Rising Demand and Access GapsAbout 1 in 6 adults experience infertility. In many countries one IVF cycle costs more than a year's income.
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in China

See all
Same topic, other categories

Related on women's health and fertility

See the topic